Ouabain activates NFκB through an NMDA signaling pathway in cultured cerebellar cells

Neuropharmacology

Volumn 73, Issue , 2013, Pages 327-336

  De Sa Lima L ^a   Kawamoto, E M ^a   Munhoz, C D ^a   Kinoshita, P F ^a   Orellana, A M M ^a   Curi, R ^a   Rossoni, L V ^a   Avellar, M C W ^a   Scavone, C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bdnf; Il 1 ; NF B; NMDA; OUA; Tnf

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; DIZOCILPINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MANUMYCIN; MANUMYCIN A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; OUABAIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN P50; PROTEIN TYROSINE KINASE; RAS PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; GENE EXPRESSION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

BDNF; IL-1Β; NFΚB; NMDA; OUA; TNF-Α;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBELLUM; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FLAVONOIDS; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; NF-KAPPA B; OUABAIN; POLYENES; POLYUNSATURATED ALKAMIDES; PRIMARY CELL CULTURE; PYRAZOLES; PYRIMIDINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885156550     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.06.006     Document Type: Article

References (57)

1. Adams, J.P., Sweatt, J.D., 2002. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu. Rev. Pharmacol. Toxicol. 42, 135-163.
2. Aizman, O., Uhlén, P., Lal, M., Brismar, H., Aperia, A., 2001. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc. Natl. Acad. Sci. U. S. A. 98, 13420-13424.
3. Albensi, B.C., Mattson, M.P., 2000. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35, 151-159.
4. Barger, S.W., Fiscus, R.R., Ruth, P., Hofmann, F., Mattson, M.P., 1995. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted form of β-amyloid precursor. J. Neurochem. 64, 2087-2096.
5. Bealer, S.L., Haywood, J.R., Gruber, K.A., Buckalew, V.M.J., Fink, G.D., Brody, M.J., Johnson, A.K., 1983. Preoptic-hypotalamic periventricular lesions reduce natriuresis to volume expansion. Am. J. Physiol. 244, R51-R57.
6. Bilimoria, P.M., Bonni, A., 2008. Cultures of Cerebellar Granule Neurons. Cold Spring Harb Protoc. 3 (12), 1-7.
7. Blaustein, M.P., Lederer, W.J., 1999. Sodium/calcium exchange: its physiological implications. Physiol. Rev. 79, 763-854.
8. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
9. Burr, P.B., Morris, B.J., 2002. Involvement of NMDA receptors and a p21Ras-like guanosine triphosphatase in the constitutive activation of nuclear factorkappa-B in cortical neurons. Exp. Brain Res. 147, 273-279.
10. Contestabile, A., 2002. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survivalin vivo and in vitro. The Cerebellum 1, 41-55.
11. Coyle, J.T., Puttfarcken, P., 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
12. Cruise, L., Ho, L.K., Veitch, K., Fuller, G., Morris, B.J., 2000. Kainate receptors activate NF-kappaB via MAP kinase in striatal neurones. Neuroreport 11, 395-398.
13. de Lima, T.M., de Sa Lima, L., Scavone, C., Curi, R., 2006. Fatty acid control of nitric oxide production by macrophages. FEBS Lett. 580, 3287-3295.
14. Decker, T., Lohmann-Matthes, M.L., 1988. A quick and simple method for the quantitation of lactate dehydrogenase releasein measurements ofcellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 115, 61-69.
15. Desfrere, L., Karlsson, M., Hiyoshi, H., Malmersjö, S., Nanou, E., Estrada, M., Miyakawa, A., Lagercrantz, H., El Manira, A., Lal, M., Uhlén, P., 2009. Na, K-ATPase signal transduction triggers CREB activation and dendritic growth. Proc. Natl. Acad. Sci. U. S. A. 106, 2212-2217.
16. Dvela, M., Rosen, H., Ben-Ami, H.C., David Lichtstein, D., 2012. Endogenous ouabain regulates cell viability. Am. J. Physiol. Cell Physiol. 302, C442-C452.
17. Gallo, V., Suergiu, R., Levi, G., 1987. Functional evaluation of glutamate receptor subtypes in cultured cerebellar neurones and astrocytes. Eur. J. Pharmacol. 138.
18. Ghosh, S., Karin, M., 2002. Missing pieces in the NF-kappaB puzzle. Cell 109, S81-S96.
19. Ghosh, S., May, M.J., Kopp, E.B., 1998. NF-κB and rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
20. Golden, W.C., Martin, L.J., 2006. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear BLC-2 in vivo. Neuroscience 37, 133-144.
21. Guerrini, L., Blasi, F., Denis-Donini, S., 1995. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. U. S. A. 92, 9077-9081.
22. Hansen, M.B., Nielson, S.E., Berg, K., 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210.
23. Hoffmann, A., Baltimore, D., 2006. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210, 171-186.
24. Jiang, X., Tian, F., Mearow, K., Okagaki, P., Lipsky, R.H., Marini, A.M., 2005. The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J. Neurochem. 94, 713-722.
25. Kaltschmidt, C., Kaltschmidt, B., Baeuerle, P., 1995. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc. Natl. Acad. Sci. U. S. A. 92, 9618-9622.
26. Kawamoto, E., Lima, L., Munhoz, C., Yshii, L., Kinoshita, P., Amara, F., Pestana, R., Orellana, A., Cipolla-Neto, J., Britto, L., Avellar, M., Rossoni, L., Scavone, C., 2012. Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-kB in the rat hippocampus. J. Neurosci. Res. 90, 213-228.
27. Kawamoto, E.M., Lepsch, L.B., Boaventura, M.F., Munhoz, C.D., Lima, L.S., Yshii, L.M., Avellar, M.C., Curi, R., Mattson, M.P., Scavone, C., 2008. Amyloid beta-peptide activates nuclear factor-kappaB through an N-methyl-D-aspartate signaling pathway in cultured cerebellar cells. J. Neurosci. Res. 86, 845-860.
28. Kotova, O., Al-Khalili, L., Talia, S., Hooke, C., Fedorova, O.V., Bagrov, A.Y., Chibalin, A.V., 2006. Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism. J. Biol. Chem. 281, 20085-20094.
29. Li, J., Zelenin, S., Aperia, A., Aizman, O., 2006. Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J. Am. Soc. Nephrol. 17, 1848-1857.
30. Li, Z., Xie, Z., 2009. The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Arch. - Eur. J. Physiol. 457, 635-644.
31. Liang, M., Cai, T., Tian, J., Qu, W., Xie, Z.J., 2006. Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. J. Biol. Chem. 281, 19709-19719.
32. Lipsky, R.H., Xu, K., Zhu, D., Kelly, C., Terhakopian, A., Novelli, A., Marini, A.M., 2001. Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. J. Neurochem. 78, 254-264.
33. Liu, X.L., Miyakawa, A., Aperia, A., Krieger, P., 2007. Na, K-ATPase generates calcium oscillations in hippocampal astrocytes. NeuroReport 18, 597-600.
34. Mattson, M.P., Camandola, S., 2001. NF-kB in neuronal plasticity and neurodegeneratives disorders. J. Clin. Invest. 107, 247-254.
35. Mattson, M.P., Goodman, Y., Luo, H., Fu, W., Furukawa, K., 1997. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
36. Mattson, M.P., Meffert, M.K., 2006. Roles for NF-KB in nerve cell survival, plasticity and disease. Cell Death Differ. 6, 1-9.
37. McGeer, P.L., Rogers, J., McGeer, E.G., 2006. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis. 9, S271-S276.
38. Mckee, M., Scavone, C., Nathanson, J.A., 1994. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc. Natl. Acad. Sci. U. S. A. 91, 12056-12060.
39. Newman, R.A., Yang, P., Pawlus, A.D., Block, K.I., 2008. Cardiac glycosides as novel cancer therapeutic agents. Mol. Interv. 8, 36-49.
40. O'Neill, L.A.J., Kaltschmidt, C., 1997. NF-kB: a crucial trasncription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
41. Orlov, S.N., Taurin, S., Hamet, P., 2002. The alpha1-Na/K pump does not mediate the involvement of ouabain in the development of hypertension in rats. Blood Press. 11, 56-62.
42. Orlov, S.N., Thorin-Trescases, N., Pchejetski, D., Taurin, S., Farhat, N., Tremblay, J., Thorin, E., Hamet, P., 2004. Na/K pump and endothelial cell survival: [Na]i/[K] iindependent necrosis triggered by ouabain, and protection against apoptosis mediated by elevation of [Na]i. Pflugers Arch. 448, 335-345.
43. + pump in some models of experimental hypertension. Hypertension 3, II96-II101.
44. Petrushanko, I., Bogdanov, N., Lapina, N., Boldyrev, A., Gassmann, M., Bogdanova, A., 2007. Oxygen-induced Regulation of Na/K ATPase in cerebellar granule cells. J. Gen. Physiol. 130, 389-398.
45. Rong, Y., Baudry, M., 1996. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J. Neurochem. 67, 662-668.
46. Salinovich, O., Montelaro, R., 1986. Reversible staining and peptide mapping of protein transferred to nitrocellulose after separation by SDS-PAGE. Anal. Biochem. 156, 341-347.
47. Schneider, R., Wray, V., Nimtz, M., Lehmann, W.D., Kirch, U., Antolovic, R., Schoner, W., 1998. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J. Biol. Chem. 273, 784-792.
48. Schoner, W., Scheiner-Bobis, G., 2007. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 293, C509-C536.
49. Soltoff, S.P., Heeden, L., 2008. Regulation of ERK 1/2 by ouabain and Na-K-ATPase-dependent energy utilization and AMPK activation in parotid acinar cells. Am. J. Physiol. Cell Physiol. 295, C590-C599.
50. +-Pump activity. Hypertension 4, 575-580.
51. Srinivasan, D., Yen, J.-H., Joseph, D.J., Friedman, W., 2004. Cell type-specific Interleukin-1{beta} signaling in the CNS. J. Neurosci. 24, 6482-6488.
52. +-ATPase. Biochim. Biophys. Acta 988, 185-220.
53. Thangnipon, W., Kingsbury, A., Webb, M., Balazs, R., 1983. Observations on rat cerebellar cells in vitro: influence of substratum, potassium concentration and relationship between neurones and astrocytes. Brain Res. Dev. Brain Res. 11, 177-189.
54. +-ATPase forms a functional signaling complex. Mol. Biol. Cell 17, 317-326.
55. Valente, R.C., Capella, L.S., Monteiro, R.Q., Rumjanek, V.M., Lopes, A.G., Capella, M.A., 2003. Mechanisms of ouabain toxicity. FASEB J. 17, 1700-1702.
56. +)-ATPase as a signal transducer. Eur. J. Biochem. 269, 2434-2439.
57. Yu, Z., Zhou, D., Bruce-Keller, A.J., Kindy, M.S., Mattson, M.P., 1999. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci., 8856-8865.